Here are relevant reports on : live-sound-reinforcement-market
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at USD4.39 billion in 2025, stood at USD4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Value Added Services (VAS) Market (Content Provider , Customer Delight, Online Gaming, Utility Services, Live Streaming, SMS, MMS, Mobile Money & M-commerce based services, M-health) - Advancements, Forecasts & Analysis (2014 - 2019)
Value added services (VAS) market in the emerging nations have immense potential. Affordable mobile devices and cheaper data subscription rates are expected to push the mobile value added services market further.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at USD3.84 billion in 2025, stood at USD4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of USD5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Military Simulation and Training Market by Application (Army, Aviation, Naval), Type (Live, Virtual, Constructive), Platform (Land, Maritime, Airborne), Solution, Environment (Synthetic, Gaming), Technology, and Region - Global Forecast
The Military Simulation and Training market size is projected to reach USD 12.2 billion by 2027, at a CAGR of 5.6% during the forecast period. This region is expected to lead the market from 2021 to 2026, owing to increased investments and the adoption of advanced military simulators for all the platforms by countries in this region. The presence of prominent manufacturers and integrators of these Military Simulation and Training, including Lockheed Martin (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), and Raytheon Technologies (US), is also expected drive the market in the region over the forecast period.
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Military vaccination Market (Live attenuated Vaccine, Inactivated/Killed vaccine, Toxoid vaccine & Subunit/conjugate vaccine), Immunization ( active & passive), Troop health protection (First Aid & Surgical Instruments) & By Geography - Forecast & Analysis(2014-2020)
In armed forces across the globe, the armed personals are given vaccine and are immunized from the external viruses in order to continuously improve the readiness of the army men and women for any kind of emergency situations. It is very important to keep the armed personals healthy as they play a crucial role in safeguarding the people of the nations. To provide the healthy and protected environment for the defense personals and their families, the vaccines and the immunizing agents are provided to the armed personals at proper schedule or during the case of emergencies.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at USD10.94 billion in 2024, stood at USD11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of USD16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Silent Generator Market by Sound Level (Super Silent, Silent), Fuel (Diesel, Natural Gas), Power Rating (Up to 25 kVA, 25–49 kVA, 50–99 kVA, 100–499 kVA, & Above 500 kVA), Phase, Type, Application, End User, and Region - Global Forecast to 2030
The global silent generator market is estimated to be valued at USD 3.58 billion in 2025 and is projected to reach USD 4.95 billion by 2030, growing at a CAGR of 6.7%. Some major players in the silent generator market are Cummins Inc. (US), Rolls-Royce plc(US), Atlas Copco (Sweden), Generac (US), and Honda (Japan). The major strategies adopted by these players include product launches, acquisitions, expansions, agreements, investments, and contracts.
- Published: September 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50